These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 6273645)

  • 1. Natriuretic hormone - a circulating inhibitor of sodium- and potassium-activated adenosine triphosphatase. Its potential role in body fluid and blood pressure regulation.
    Kramer HJ
    Klin Wochenschr; 1981 Nov; 59(22):1225-30. PubMed ID: 6273645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of endogenous inhibition of Na-K-ATPase in human hypertension--sodium pump activity as a determinant of peripheral vascular resistance.
    Kramer HJ; Glänzer K; Sorger M
    Clin Exp Hypertens A; 1985; 7(5-6):769-82. PubMed ID: 2990771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the role of sodium- and potassium-activated adenosine triphosphatase inhibition in the pathogenesis of human hypertension. Changes in vascular and cardiac function following inhibition of the sodium pump in normotensive subjects and effects of calcium entry blockade.
    Kramer HJ; Glänzer K; Freitag T; Schönfeld J; Sorger M; Schlebusch H; Düsing R; Krück F
    Klin Wochenschr; 1985 Jan; 63(1):32-6. PubMed ID: 2579261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous natriuretic and ouabain-like factors. Their roles in body fluid volume and blood pressure regulation.
    Kramer HJ; Meyer-Lehnert H; Michel H; Predel HG
    Am J Hypertens; 1991 Jan; 4(1 Pt 1):81-9. PubMed ID: 1848764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digitalislike circulating factor in hypertension: potential messenger between salt balance and intracellular sodium.
    Haddy FJ
    Cardiovasc Drugs Ther; 1990 Mar; 4 Suppl 2():343-9. PubMed ID: 2176807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Endogenous natriuretic and ouabain-like factors. Their potential role in volume and blood pressure regulation].
    Kramer HJ; Bäcker A; Krampitz G; Meyer-Lehnert H; Michel H
    Klin Wochenschr; 1990 Nov; 68(22):1112-8. PubMed ID: 2177810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on ouabain-like endogenous natriuretic factors in human urine. Inhibition of Na-K-ATPase and 3H-ouabain binding.
    Kramer HJ; Baecker A; Weiler E; Liddiard C
    Klin Wochenschr; 1986 Aug; 64(16):760-6. PubMed ID: 3020314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natriuresis and inhibition of Na+/K(+)-ATPase: modulation of response by physiological manipulation.
    McDougall JG; Yates NA
    Clin Exp Pharmacol Physiol Suppl; 1998 Nov; 25():S57-60. PubMed ID: 9809194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium transport inhibition, cell calcium, and hypertension. The natriuretic hormone/Na+-Ca2+ exchange/hypertension hypothesis.
    Blaustein MP; Hamlyn JM
    Am J Med; 1984 Oct; 77(4A):45-59. PubMed ID: 6091450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Presence and regulation of plasma with natriuretic and Na-K ATPase inhibitory properties in normotensive subjects].
    Krzesinski JM; Potier JP; Godon JP; Rorive GL
    Arch Mal Coeur Vaiss; 1987 Jun; 80(6):960-5. PubMed ID: 2821949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potassium, Na+-K+ pump inhibitor and low-renin hypertension.
    Haddy FJ
    Clin Invest Med; 1987 Nov; 10(6):547-54. PubMed ID: 2831002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of lead and natriuretic hormone on kinetics of sodium-potassium-activated adenosine triphosphatase: possible relevance to hypertension.
    Weiler E; Khalil-Manesh F; Gonick H
    Environ Health Perspect; 1988 Jun; 78():113-7. PubMed ID: 2849538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blunted natriuretic response to human urine extracts with Na+,K(+)-ATPase inhibiting activity in experimental cirrhosis.
    Asbert M; Clària J; Jiménez W; Arroyo V; Ros J; Gaya J; Rivera F; Rodés J
    J Hepatol; 1994 May; 20(5):660-5. PubMed ID: 8071545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natriuretic and smooth muscle responses to human urinary natriuretic hormone in rats: relation to blood pressure and kallikrein excretion in patients.
    Mills IH; Chakravarty B; Brownlee A; Lee G; Mortimer W
    Clin Exp Hypertens A; 1985; 7(5-6):783-92. PubMed ID: 2990772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Volume hormones and blood pressure.
    Genest J
    Ann Intern Med; 1983 May; 98(5 Pt 2):744-9. PubMed ID: 6303174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ouabain-like factors in human urine: identification of a Na-K-ATPase inhibitor as vanadium-diascorbate adduct.
    Kramer HJ; Krampitz G; Bäcker A; Meyer-Lehnert H
    Clin Exp Hypertens; 1998; 20(5-6):557-71. PubMed ID: 9682912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytochemical demonstration of an endogenous inhibitor of Na-K ATPase and its relationship to familial arterial hypertension].
    de Wardener H
    Nephrologie; 1987; 8(1):3-6. PubMed ID: 3035398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relation of a circulating sodium transport inhibitor (the natriuretic hormone?) to hypertension.
    de Wardener HE; MacGregor GA
    Medicine (Baltimore); 1983 Sep; 62(5):310-26. PubMed ID: 6312247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating inhibitor of sodium-potassium-activated adenosine triphosphatase after expansion of extracellular fluid volume in rats.
    Gonick HC; Kramer HJ; Paul W; Lu E
    Clin Sci Mol Med; 1977 Oct; 53(4):329-34. PubMed ID: 144041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between the sympathetic nervous system and sodium potassium adenosine triphosphatase inhibitor in salt-sensitive patients with essential hypertension.
    Nishio I; Shima H; Tsuda K; Hano T; Masuyama Y
    J Hypertens Suppl; 1988 Dec; 6(4):S216-8. PubMed ID: 2853728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.